COVID-19 Therapeutic Management and Prevention
This series discusses FDA approved COVID-19 therapies for both the inpatient and outpatient settings, off label therapies, and preventive modalities. This roundtable features a panel of clinicians including Tina Tan, MD, Scott Roberts, MD, James Wilson, DO, FACP, FAWM, CTropMed, and Michael Curulewski, PharmD, BCPS, BCIDP, BCGP.
